Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

NCT02325492 is registered in ClinicalTrials.gov with Galmed Pharmaceuticals Ltd as lead sponsor.

NCT NCT02325492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02325492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study
Lead sponsor
Galmed Pharmaceuticals Ltd
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2014
Completion date
October 31, 2015
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gallstones